Pilot Project for the DTMI CRA Program

描述（由申请人提供）：本试点研究的总体目标是评估在杜克大学转化医学研究所（DTMI）内建立研究助理组织（RAO）的可行性、方法和经济性。DTMI社区研究协会（DTMI CRA）项目旨在消除在社区实践中进行临床研究的行政负担，增加社区提供者在产生研究结果以支持循证实践方面的参与，并提高研究结果对更广泛人群的普遍性。这将通过建立一个教育计划和发展一个满足社区提供者需求的研究基础设施来实现。DTMI CRA项目将涵盖整个医疗保健领域，包括医院、提供者办公室、公共卫生诊所和社区参与者。

DESCRIPTION (provided by applicant): The overall goal of this pilot study is to evaluate the feasibility, methodology, and economics of setting up a Research Associates Organization (RAO) within the Duke University Translational Medicine Institute (DTMI). The DTMI Community Research Associates (DTMI CRA) program aims to remove administrative burdens to performing clinical research within community practices, increase participation of community providers in generating findings to support evidence-based practices, and enhance the generalizability of research findings to a broader population. This will be accomplished through establishing an educational program and developing a research infrastructure that meets the needs of the community providers. The DTMI CRA program will encompass the entire spectrum of healthcare with representation of hospitals, provider offices, public health clinics, and community participants. To address these goals, the study proposes the following specific aims to: 1) assess the proportion of community providers with an interest in clinical research participation at different levels via a mailed and online survey; 2) compile online training modules on good clinical practices, research ethics, and community health tailored for community providers, followed by an assessment of the time for completion, feedback, and satisfaction with training; 3) assess the components of clinical research support required by practice sites, then tailor clinical research support to the needs of the community practice; 4) inventory the number and type of clinical research studies available throughout the Duke University enterprise that would be appropriate for community provider involvement; 5) summarize the feasibility, methodology, and costs; 6) assess current participation of community practitioners in ongoing research projects, and initiate a new community-based clinical trial for evaluation relative to the findings of Aims 1-5; and 7) participate actively in the network created by this Cooperative Agreement to create a national system.